Oral tablets designed for the rapid relief of acute migraine attacks. The tablet dissolves quickly on the tongue, ensuring fast absorption and effective relief. It works by selectively stimulating serotonin 5-HT₁B/₁D receptors, leading to constriction of intracranial blood vessels and inhibition of inflammatory neuropeptide release, which helps relieve migraine pain and associated symptoms.

Indications:
- Used for the treatment of acute migraine attacks, with or without aura.
- Not intended for the prevention of migraine headaches or the management of hemiplegic or basilar migraine.

Main Active Ingredients:
- Rizatriptan 5 mg.

Precautions:
- Use only after confirming the diagnosis of migraine.
- Avoid use in patients with uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders.
- Not recommended for patients with severe hepatic or renal impairment.
- Should not be used within 24 hours of taking another triptan or ergotamine-containing medication.
- Use caution when driving or operating machinery due to possible drowsiness or dizziness.
- Not recommended for use during pregnancy or breastfeeding without medical advice.

Side Effects:
- Dizziness.
- Fatigue.
- Dry mouth.
- Nausea.
- Chest discomfort or tightness.
- Somnolence.

Drug–Drug Interactions:
- Contraindicated with monoamine oxidase inhibitors such as Phenelzine, Tranylcypromine, or Isocarboxazid.
- Caution when used with selective serotonin reuptake inhibitors such as Fluoxetine, Paroxetine, or Sertraline, serotonin–norepinephrine reuptake inhibitors such as Venlafaxine or Duloxetine, or tricyclic antidepressants such as Amitriptyline or Clomipramine.
- Avoid concurrent use with other triptans such as Sumatriptan or Zolmitriptan, or with ergotamine-containing medications such as Ergotamine or Dihydroergotamine.
- May interact with Propranolol, requiring dose adjustment of Rizatriptan.